Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample Size For The Study On Long Read Sequencing Market:
1.3.1.1 Primary Sources:
1.3.1.2 Secondary Data Sources:
1.4 Information Or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: Cagr Calculation
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary, 2021
2.2 Market Segmentation
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Advantages Of Long Read Sequencing
3.1.1.2 Potential Applications In Clinical Sequencing And Analysis
3.1.1.3 Advancements In Data Analysis
3.1.2 Market Restraint Analysis
3.1.2.1 High Cost
3.1.2.2 Technological Challenges
3.2 Penetration And Growth Prospect Mapping For Application, 2021 (Usd Million)
3.3 Impact Of Covid-19 Pandemic On Global Long Read Sequencing Market
3.3.1 The Evolving Use Of Long Read Sequencing During Covid-19 Pandemic
3.4 Business Environment Analysis
3.4.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.4.2 Porter’s Five Forces Analysis
Chapter 4 Long Read Sequencing Market: Technology Business Analysis
4.1 Long Read Sequencing Market: Technology Movement Analysis
4.2 Single-Molecule Real-Time Sequencing (Smrt)
4.2.1 Global Smrt Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Nanopore Sequencing
4.3.1 Global Nanopore Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Long Read Sequencing Market: Product Business Analysis
5.1 Long Read Sequencing Market: Product Movement Analysis
5.2 Instruments
5.2.1 Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Consumables
5.3.1 Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Services
5.4.1 Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Long Read Sequencing Market: Application Business Analysis
6.1 Long Read Sequencing Market: Application Movement Analysis
6.2 Identification & Fine Mapping Of Structural Variation
6.2.1 Long Read Sequencing Market Estimates And Forecast For Identification & Fine Mapping Of Structural Variation, 2018 – 2030 (USD Million)
6.3 Tandem Repeat Sequencing
6.3.1 Market Estimates And Forecast For Tandem Repeat Sequencing, 2018 – 2030 (USD Million)
6.4 Pseudogene Discrimination
6.4.1 Market Estimates And Forecast For Pseudogene Discrimination, 2018 – 2030 (USD Million)
6.5 Resolving Allele Phasing
6.5.1 Market Estimates And Forecast For Resolving Allele Phasing, 2018 – 2030 (USD Million)
6.6 Reproductive Genomics
6.6.1 Market Estimates And Forecast For Reproductive Genomics, 2018 – 2030 (USD Million)
6.7 Cancer
6.7.1 Market Estimates And Forecast For Cancer, 2018 – 2030 (USD Million)
6.8 Viral & Microbial Sequencing
6.8.1 Market Estimates And Forecast For Viral & Microbial Sequencing, 2018 – 2030 (USD Million)
6.9 Other
6.9.1 Market Estimates And Forecast For Other Applications, 2018 – 2030 (USD Million)
Chapter 7 Long Read Sequencing Market: Workflow Business Analysis
7.1 Long Read Sequencing Market: Workflow Movement Analysis
7.2 Pre-Sequencing
7.2.1 Market Estimates And Forecast For Pre-Sequencing, 2018 – 2030 (USD Million)
7.3 Sequencing
7.3.1 Market Estimates And Forecast For Sequencing, 2018 – 2030 (USD Million)
7.4 Data-Analysis
7.4.1 Market Estimates And Forecast For Data Analysis, 2018 – 2030 (USD Million)
Chapter 8 Long Read Sequencing Market: End-Use Business Analysis
8.1 Long Read Sequencing Market: End-Use Movement Analysis
8.2 Academic Research
8.2.1 Market For Academic Research, 2018 – 2030 (USD Million)
8.3 Clinical Research
8.3.1 Market For Clinical Research, 2018 – 2030 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Market For Hospitals & Clinics, 2018 – 2030 (USD Million)
8.5 Pharma & Biotech Entities
8.5.1 Market For Pharma & Biotech Entities, 2018 – 2030 (USD Million)
8.6 Other End-Users
8.6.1 Market For Other End-Users, 2018 – 2030 (USD Million)
Chapter 9 Long Read Sequencing Market: Regional Business Analysis
9.1 Long Read Sequencing Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Market Estimates And Forecast, 2018-2030, Usd Million
9.2.2 U.S.
9.2.2.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.2.3 Canada
9.2.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3 Europe
9.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3.2 Germany
9.3.2.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3.3 Uk
9.3.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3.4 France
9.3.4.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3.5 Spain
9.3.5.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.3.6 Italy
9.3.6.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.4 Asia-Pacific
9.4.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.4.2 China
9.4.2.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.4.3 India
9.4.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.4.4 Japan
9.4.4.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.4.5 South Korea
9.4.5.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.5 Latin America
9.5.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.5.2 Brazil
9.5.2.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.5.3 Mexico
9.5.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.6 MEA
9.6.1 Middle East Africa Market Estimates And Forecast, 2018-2030, Usd Million
9.6.2 South Africa
9.6.2.1 Market Estimates And Forecast, 2018-2030, Usd Million
9.6.3 Saudi Arabia
9.6.3.1 Market Estimates And Forecast, 2018-2030, Usd Million
Chapter 10 Company Profiles
10.1 Company Profiles
10.1.1 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 OXFORD NANOPORE TECHNOLOGIES LIMITED
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 QUANTAPORE, INC.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 STRATOS GENOMICS INC.
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 MICROBESNG
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 INSTITUTE OF INTEGRATIVE BIOLOGY OF THE CELL (I2BC)
10.1.6.1 Company overview
10.1.6.2 Pall Corporation
10.1.6.3 Financial performance
10.1.6.4 Product benchmarking
10.1.6.5 Strategic initiatives
10.1.7 BASECLEAR B.V.
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 FUTURE GENOMICS TECHNOLOGIES B.V.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 GARVAN INSTITUTE OF MEDICAL RESEARCH
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.10 GENOME TRANSCRIPTOME FACILITY OF BORDEAUX
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 NEXTOMICS
10.1.11.1 Company overview
10.1.11.2 Financial performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 TAKARA BIO INC.
10.1.12.1 Company overview
10.1.12.2 Financial performance
10.1.12.3 Product benchmarking